Study of blood disorders in families with a history
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study looks at blood-related conditions that run in families, including people with the condition and their close relatives. It may help doctors better understand what drives these inherited blood disorders and how to manage them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your relative) have a blood condition called LPD.
- There is a family history of LPD (a close family member also has it).
- If you are being studied as a relative, you must be a blood relative of someone with LPD (or you may be in a comparison group if not).
- You must agree to take part by signing the informed consent form.
- You cannot be pregnant to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at families where more than one close, blood-related person has a lymphoproliferative disorder (a group of conditions where the lymph system makes too many abnormal cells). It aims to better understand why these disorders run in families and how they may be inherited or related.
This study looks at what leads to specific blood cancers and related blood disorders. If you have one of the listed conditions (or are being evaluated for it), you may be asked to join research that helps doctors understand why these illnesses happen.
This study collects and stores tumor/tissue information and family medical history from people with certain blood cancers. It aims to help researchers understand why these illnesses may run in families and use genetic clues for future research.
This study follows people with certain slow-growing blood cancers (CLL/SLL, LPL/WM, and related conditions) to understand how they progress and what leads to needing treatment. It may help doctors predict changes over time and plan care more effectively.
This trial studies how the body makes blood cells in people with chronic lymphocytic leukemia (CLL), a related condition called monoclonal B-cell lymphocytosis (MBL), and in healthy volunteers matched by age. The goal is to understand differences that may help improve treatment or monitoring.
This study looks at what it’s like to live with chronic lymphocytic leukemia while participating in a clinical research protocol. It may help researchers understand patient experiences and improve how future trials are run.
Hear when a new Lymphoproliferative Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.